益升医学 (870450.OC)

+ 收藏

现金流量表(益升医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 15,968,480.4559,090,583.4126,021,293.7730,681,945.5212,678,526.84
 收到其他与经营活动有关的现金(元) 154,603.362,096,781.811,626,684.715,073,037.743,869,591.59
 经营活动现金流入小计(元) 16,123,083.8161,187,365.2227,647,978.4835,754,983.2616,548,118.43
 购买商品、接受劳务支付的现金(元) 8,670,154.9929,514,482.476,822,439.6314,317,361.6011,365,489.96
 支付给职工以及为职工支付的现金(元) 4,559,141.468,094,786.553,309,160.526,426,061.672,810,706.61
 支付的各项税费(元) 2,254,588.061,619,767.45336,159.81376,776.7594,634.88
 支付其他与经营活动有关的现金(元) 5,013,553.6617,643,451.1810,527,399.0311,836,530.403,900,462.33
 经营活动现金流出小计(元) 20,497,438.1756,872,487.6520,995,158.9932,956,730.4218,171,293.78
 经营活动产生的现金流量净额(元) -4,374,354.364,314,877.576,652,819.492,798,252.84-1,623,175.35
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -1,411,454.50-1,502,697.42-
 投资活动现金流入小计(元) -1,411,454.50-1,502,697.42-
 投资活动产生的现金流量净额(元) -1,411,454.50-1,502,697.42-
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 2,500,000.0024,819,200.006,416,000.0016,144,500.006,300,000.00
 收到其他与筹资活动有关的现金(元) -887,049.5827,049.583,250,000.00-
 筹资活动现金流入小计(元) 2,500,000.0025,706,249.586,443,049.5819,394,500.006,300,000.00
 偿还债务支付的现金(元) 3,500,000.0024,852,072.068,992,872.0619,721,424.475,632,860.69
 分配股利、利润或偿付利息支付的现金(元) 114,123.61354,413.53207,614.49509,751.80201,658.74
 支付其他与筹资活动有关的现金(元) -2,500,000.00-3,339,500.00-
 筹资活动现金流出小计(元) 3,614,123.6127,706,485.599,200,486.5523,570,676.275,834,519.43
 筹资活动产生的现金流量净额(元) -1,114,123.61-2,000,236.01-2,757,436.97-4,176,176.27465,480.57
五、现金及现金等价物净增加额(元) -5,488,477.973,726,096.063,895,382.52124,773.99-1,157,694.78
 加:期初现金及现金等价物余额(元) 5,760,996.182,034,900.122,034,900.121,910,126.131,910,119.66
 期末现金及现金等价物余额(元) 272,518.215,760,996.185,930,282.642,034,900.12752,424.88
补充资料:
 净利润(元) 1,305,732.005,178,390.98861,487.58-4,038,305.30-61,250.57
 固定资产和投资性房地产折旧(元) 1,566,096.723,210,058.401,621,767.743,339,529.281,681,921.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,566,096.723,210,058.401,621,767.743,339,529.281,681,921.92
 处置固定资产、无形资产和其他长期资产的损失(元) --1,411,454.50-1,420,441.52-1,502,697.42-
 财务费用(元) 114,509.01361,940.98235,872.36519,589.57264,561.89
 递延所得税(元) -13,531.41-14,127.66-
  其中:递延所得税资产减少(元) -13,531.41-14,127.66-
 存货的减少(元) -205,413.53-7,822,272.47-1,656,391.281,140,440.23-4,098,612.66
 经营性应收项目的减少(元) 6,491,626.43-15,659,462.873,441,406.8110,785,688.601,736,154.34
 经营性应付项目的增加(元) -13,650,879.9920,440,170.643,693,891.80-7,460,119.78-1,145,950.27
 现金的期末余额(元) 272,518.215,760,996.185,930,282.642,034,900.12752,424.88
 减:现金的期初余额(元) 5,760,996.182,034,900.121,910,126.131,910,126.131,910,119.66
 现金及现金等价物的净增加额(元) -5,488,477.973,726,096.064,020,156.51124,773.99-1,157,694.78
公告日期 2024-08-202024-04-252023-08-172023-04-262022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院